Literature DB >> 22551928

Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Jacob Osterbur1, Leslee Sprague, Maria Muccioli, Michelle Pate, Kristen Mansfield, John McGinty, Yihan Li, Yandi Li, Venktesh Shirure, Maria Cecilia Courreges, Fabian Benencia.   

Abstract

Dendritic cells (DCs) are antigen presenting cells capable of inducing specific immune responses against microbial infections, transplant antigens, or tumors. DCs have been shown to possess a high plasticity showing different phenotypes in response to their microenvironment. For example, tumor-associated DCs can acquire an angiogenic phenotype thus promoting tumor growth. Further, DCs cultured in vitro under different conditions are able to upregulate the expression of endothelial markers and to express angiogenic factors. Indeed, it has been shown that soluble factors such as VEGF of PGE-2, that are present in the microenvironment of several tumors, affect the biology of these cells. We hypothesize that in addition to soluble factors the adhesion to different substrates will also define the phenotype and function of DCs. Herewith we demonstrate that murine myeloid(m) DCs upregulate endothelial markers such as VE-Cadherin, and to a lesser extent TIE-2, and decrease their immune capabilities when cultured on solid surfaces as compared with the same cells cultured on ultra-low binding (ULB) surfaces. On the other hand, the expression of angiogenic molecules at the level of RNA was not different among these cultures. In order to further investigate this phenomenon we used the murine ID8 model of ovarian cancer which can generate solid tumors when cancer cells are injected subcutaneously or a malignant ascites when they are injected intraperitoneally. This model gave us the unique opportunity to investigate DCs in suspension or attached to solid surfaces under the influence of the same tumor cells. We were able to determine that DCs present in solid tumors showed higher levels of expression of endothelial markers and angiogenic molecules but were not able to respond to inflammatory stimuli at the same extent as DCs recovered from ascites. Moreover, mDCs cultured on ULB surfaces in the presence of tumor factors do not expressed endothelial markers. Taking into account all these data we consider that tumor factors might be responsible for inducing angiogenic properties in DCs, but that in some settings the expression of endothelial markers such as VE-Cadherin and TIE-2 might be a function of attachment to solid surfaces and independent of the angiogenic properties of these cells.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551928      PMCID: PMC3413747          DOI: 10.1016/j.imbio.2012.02.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  76 in total

Review 1.  Immunobiology of dendritic cells.

Authors:  J Banchereau; F Briere; C Caux; J Davoust; S Lebecque; Y J Liu; B Pulendran; K Palucka
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Dendritic cells derived from peripheral monocytes express endothelial markers and in the presence of angiogenic growth factors differentiate into endothelial-like cells.

Authors:  B Fernandez Pujol; F C Lucibello; M Zuzarte; P Lütjens; R Müller; K Havemann
Journal:  Eur J Cell Biol       Date:  2001-01       Impact factor: 4.492

Review 4.  The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

Review 5.  Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling.

Authors:  S Patan
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Authors:  Leslee Sprague; Maria Muccioli; Michelle Pate; Evan Meles; John McGinty; Harika Nandigam; Amritha K Venkatesh; Ming-Yu Gu; Kristen Mansfield; Andrew Rutowski; Omowaleola Omosebi; Maria C Courreges; Fabian Benencia
Journal:  BMC Immunol       Date:  2011-06-06       Impact factor: 3.615

7.  HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer.

Authors:  Fabian Benencia; Maria C Courrèges; José R Conejo-García; Alisha Mohamed-Hadley; Lin Zhang; Ronald J Buckanovich; Richard Carroll; Nigel Fraser; George Coukos
Journal:  Mol Ther       Date:  2005-05-31       Impact factor: 11.454

8.  Endothelial-like cells derived from human CD14 positive monocytes.

Authors:  B Fernandez Pujol; F C Lucibello; U M Gehling; K Lindemann; N Weidner; M L Zuzarte; J Adamkiewicz; H P Elsässer; R Müller; K Havemann
Journal:  Differentiation       Date:  2000-05       Impact factor: 3.880

9.  Development of a syngeneic mouse model for events related to ovarian cancer.

Authors:  K F Roby; C C Taylor; J P Sweetwood; Y Cheng; J L Pace; O Tawfik; D L Persons; P G Smith; P F Terranova
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

10.  Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies.

Authors:  Maria Muccioli; Michelle Pate; Omowaleola Omosebi; Fabian Benencia
Journal:  J Vis Exp       Date:  2011-06-02       Impact factor: 1.355

View more
  2 in total

1.  CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.

Authors:  Venktesh S Shirure; Tiantian Liu; Luis F Delgadillo; Chaz M Cuckler; David F J Tees; Fabian Benencia; Douglas J Goetz; Monica M Burdick
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-22       Impact factor: 4.249

Review 2.  Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies.

Authors:  Fabian Benencia; Maria Muccioli; Mawadda Alnaeeli
Journal:  Front Oncol       Date:  2014-04-07       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.